Поисковый запрос: (<.>S=ATSM<.>) |
Общее количество найденных документов : 23
Показаны документы с 1 по 20
|
|
1.
| Evaluation of rapid dual-tracer {62}Cu-PTSM+ {62}Cu-ATSM PET in dogs with spontaneously occurring tumors // Phys. Med. and Biol., 2008. Vol. 53, N 1.-С.217-232
|
2.
| Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting // Phys. Med. and Biol., 2008. Vol. 53, N 15.-С.4153-4167
|
3.
| Evaluation of rapid dual-tracer {62}Cu-PTSM+ {62}Cu-ATSM PET in dogs with spontaneously occurring tumors // Phys. Med. and Biol., 2008. Vol. 53, N 1.-С.217-232
|
4.
| Imaging hypoxia in vivo by controlling the electrochemistry of copper radionuclide complexes // J. Labell. Compounds and Radiopharm., 2007. Vol. 50, N 5-6.-С.354-359
|
5.
| Vavere Amy L. Cu-ATSM: A radiopharmaceutical for the PET imaging of hypoxia // Dalton Trans., 2007, N 43.-С.4893-4902
|
6.
| On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function // Phys. Med. and Biol., 2009. Vol. 54, N 6.-С.1483-1501
|
7.
| Dalah E. Simulation of tissue activity curves of {64}Cu-ATSM for sub-target volume delineation in radiotherapy // Phys. Med. and Biol., 2010. Vol. 55, N 3.-С.681-694
|
8.
| Predicting location of recurrence using FDG, FLT, and Cu-ATSM PET in canine sinonasal tumors treated with radiotherapy // Phys. Med. and Biol., 2015. Vol. 60, N 13.-С.5211-5224
|
9.
| In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals // Phys. Med. and Biol., 2009. Vol. 54, N 7.-С.2103-2119
|
10.
| Radiobiological effects of hypoxia-dependent uptake of {64}Cu-ATSM: Enhanced DNA damage and cytotoxicity in hypoxic cells // Eur. J. Nucl. Med. and Mol. Imag., 2010. Vol. 37, N 2.-С.330-338
|
11.
| Dalah E. Simulation of tissue activity curves of {64}Cu-ATSM for sub-target volume delineation in radiotherapy // Phys. Med. and Biol., 2010. Vol. 55, N 3.-С.681-694
|
12.
| In vivo assessment of tumor hypoxia in lung cancer with {60}Cu-ATSM // Eur. J. Nucl. Med. and Mol. Imag., 2003. Vol. 30, N 6.-С.844-850
|
13.
| Intratumoral administration of {64}Cu-ATSM or {61}Cu-ATSM: Therapeutic comparison in GW39 tumors // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.279
|
14.
| Intratumoral administration of {64}Cu-ATSM or {61}Cu-ATSM: Therapeutic comparison in GW39 tumors // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.279
|
15.
| Intratumoral administration of {64}Cu-ATSM or {61}Cu-ATSM: Therapeutic comparison in GW39 tumors // J. Nucl. Med., 2002. Vol. 43, N 5 прил..-С.279
|
16.
| Evaluation of copper-62 ATSM in patients with lung cancer as a hypoxic tissue tracer // J. Nucl. Med., 1998. Vol. 39, N 5 Suppl..-С.53
|
17.
| Evaluation of copper-62 ATSM in patients with lung cancer as a hypoxic tissue tracer // J. Nucl. Med., 1998. Vol. 39, N 5 Suppl..-С.53
|
18.
| MicroPET imaging of the effects of tumorcidal-2-deoxyglucose // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.80
|
19.
| Practical production of {61}Cu via {nat}Co (a, 2n) {61}Cu reaction and preparation of {61}Cu-ATSM // J. Labell. Compounds and Radiopharm., 2003. Vol. 46, прил. 1.-С.286
|
20.
| In vivo assessment of tumor hypoxia in lung cancer with {60}Cu-ATSM // Eur. J. Nucl. Med. and Mol. Imag., 2003. Vol. 30, N 6.-С.844-850
|
&uf('+1W2226#',v2226), ?>
|
|